세계의 망막 임플란트 시장 - 규모, 점유율, 동향 분석 보고서 : 유형별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Retinal Implants Market Size, Share & Trends Analysis Report By Type (Retina Implant Alpha AMS, Implantable Miniature), By End Use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

망막 임플란트 시장의 성장과 동향

망막 임플란트 세계 시장 규모는 2030년에는 8,410만 달러에 달할 것으로 예측되며, 2025-2030년 동안 CAGR 8.3%를 나타낼 것으로 예측됩니다. 시장 개척자는 지속적인 실명자에게 이용 가능한 치료 옵션이 부족하기 때문에 충족되지 않은 환자 요구를 충족시키기 위해 장치의 기술적 진보를 빠르게 개발하고 있습니다. 시력 회복 가능성, 노인 증가, 대상 질환의 유병률 증가가 망막 임플란트 수요를 밀어 올리고 있습니다. 세계 망막 장애의 빈도 증가로 시장이 확대되고 있습니다.

시력 저하를 유발하는 희귀 유전성 질환의 유병률 증가와 임상 검사의 진전에 대응하는 신규 솔루션을 개발하기 위한 연구 개척과 진보 증가가 시장을 견인하고 있습니다. MIT Technology에 게재된 기사에 따르면 미국의 약 10만명을 포함해 세계에서 추정 150만명이 망막 색소변성증입니다. 2018년 1월, Pixium Vision은 미국 FDA로부터 망막하 임플란트 PRIMA의 임상검사 개시 승인을 받았습니다. 이 임플란트는 위축성 건성 노인황반변성(AMD) 환자에게 실시가 승인되었습니다.

CDC에 따르면 황반변성, 백내장, 당뇨병성 망막증 등 노화 관련 질환은 미국에서 시력 저하와 실명의 주요 원인입니다. 40세 이상 420만 명의 미국인이 법적으로 실명 또는 부분 실명입니다. 국립 안과 실험실에 따르면, 1억 5,000만 명 이상의 미국인의 시력이 적절한 굴절 교정 수술에 의해 개선될 수 있습니다.

망막 임플란트 시장 보고서 하이라이트

• 유형에 따라 시장은 망막 임플란트 알파 AMS, 임베디드 소형 텔레스코프, Argus II 등으로 구분됩니다. Argus II 부문은 2024년에 약 34.7%의 최대 수익 점유율을 차지했습니다.
• 최종 용도별로 시장은 병원, 외래시설, 연구·제조로 구분됩니다.
• 망막 임플란트 산업의 M&A는 기업이 기술력, 제품 포트폴리오, 시장에서의 존재감을 확대하기 위해 증가하고 있습니다.
• 망막 임플란트 산업은 망막 색소 변성 및 당뇨병 성 망막증과 같은 망막 질환의 증례 증가로 인한 급속한 기술 발전과 수요 증가를 특징으로 합니다.
• 북미의 망막 임플란트 시장은 지배적인 지위를 차지하고 2024년 세계 수익 점유율의 37.5%를 획득했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 망막 임플란트 시장의 변수, 동향, 범위

• 시장 계통의 전망
  • 모 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 망막 임플란트 시장 분석 도구
  • 산업 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 망막 임플란트 시장 : 유형별, 추정·동향 분석

• 부문 대시보드
• 망막 임플란트 시장 : 유형 변동 분석
• 망막 임플란트 시장 : 유형별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 망막 임플란트 알파 AMS
• 매립형 소형 텔레스코프
• Argus II
• 기타

제5장 망막 임플란트 시장 : 최종 용도별, 추정·동향 분석

• 부문 대시보드
• 망막 임플란트 시장 : 최종 용도 변동 분석
• 망막 임플란트 시장 : 최종 용도별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 병원
• 외래시설
• 연구 및 제조

제6장 망막 임플란트 시장 :지역별, 추정·동향 분석

• 지역 대시보드
• 지역별 망막 임플란트 시장 변동 분석
• 망막 임플란트 시장 :지역 추정·동향 분석 2018-2030년
• 2018-2030년 시장 규모와 예측과 동향 분석
• 북미
  • 미국
  • 캐나다
  • 멕시코
  • 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
  • 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
  • 라틴아메리카
  • 브라질
  • 아르헨티나
  • 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 시장 진출기업의 분류
• 주요 기업 프로파일
  • Vivani Medical
  • Pixium Vision
  • Boston Retinal Implant Project
  • Nano Retina
  • Labtician Ophthalmics, Inc.
  • LambdaVision, Inc.
  • Bionic Vision Technologies
  • Nidek Co., Ltd.
  • Retina Implant AG
  • Optobionics
  • VisionCare Ophthalmic Technologies

JHS

영문 목차

영문목차

Retinal Implants Market Growth & Trends:

The global retinal implants market size is expected to reach USD 84.1 million in 2030 and is projected to grow at a CAGR of 8.3% from 2025 to 2030. The market players are rapidly developing technological advancements to the devices to cater to the unmet patient needs, Owing to the lack of treatment options available for permanently blind individuals. The potential for restoring vision, the growing senior population, and the increasing prevalence of target illnesses drive up demand for retinal implants. The market is expanding owing to the rising frequency of retinal disorders worldwide.

Increasing research developments and advancements to develop novel solutions for the growing prevalence of rare genetic conditions causing vision loss and advancing clinical trials are driving the market. According to the article published in MIT Technology, an estimated 1.5 million people worldwide, including around 100,000 people in the U.S., have retinitis pigmentosa. In January 2018, Pixium Vision received the U.S. FDA approval to initiate clinical trials for PRIMA, a sub-retinal implant. The implant was approved for practice in patients with atrophic dry Age-related Macular Degeneration (AMD).

According to the CDC, age-related diseases such as macular degeneration, cataracts, and diabetic retinopathy are the leading causes of reduced vision and blindness in the U.S. Amblyopia and strabismus are two frequent eye conditions. Legally blind or partially sighted, 4.2 million Americans aged 40 and older fall into these categories. According to the National Eye Institute, over 150 million Americans' eyesight could be improved by appropriate refractive surgery.

Retinal Implants Market Report Highlights:

• Based on the device type, the market is segmented into retina implant alpha AMS, implantable miniature telescope, Argus II, and others. The Argus II segment accounted for the largest revenue share of around 34.7% in 2024
• Based on end use, the market is segmented into hospitals, outpatient facilities, and research & manufacturing
• Mergers and acquisitions (M&A) in the retinal implants industry have been growing as companies seek to expand their technological capabilities, product portfolios, and market presence.
• The retinal implants industry is characterized by rapid technological advancements and increasing demand due to rising cases of retinal diseases like retinitis pigmentosa and diabetic retinopathy
• North American retinal implants market held a dominant position, capturing 37.5% of the global revenue share in 2024

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. End-Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. End Use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Retinal Implants Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Retinal Implants Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Retinal Implants Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Retinal Implants Market: Type Movement Analysis
• 4.3. Retinal Implants Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Retina Implant Alpha AMS
  • 4.5.1. Retina Implant Alpha AMS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Implantable Miniature Telescope
  • 4.6.1. Implantable Miniature Telescope Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Argus II
  • 4.7.1. Argus II Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Retinal Implants Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Retinal Implants Market: End Use Movement Analysis
• 5.3. Retinal Implants Market by End Use Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Hospitals
  • 5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Outpatient Facilities
  • 5.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Research & Manufacturing
  • 5.7.1. Research & Manufacturing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Retinal Implants Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Retinal Implants Market Movement Analysis
• 6.3. Retinal Implants Market: Regional Estimates & Trend Analysis 2018 to 2030 for the following
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. North America
  • 6.5.1. North America Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1 Key Country Dynamics
    • 6.5.2.2 Competitive Scenario
    • 6.5.2.3 Regulatory Framework
    • 6.5.2.4 Reimbursement scenario
    • 6.5.2.5 U.S. Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1 Key Country Dynamics
    • 6.5.3.2 Competitive Scenario
    • 6.5.3.3 Regulatory Framework
    • 6.5.3.4 Reimbursement scenario
    • 6.5.3.5 Canada Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1 Key Country Dynamics
    • 6.5.4.2 Competitive Scenario
    • 6.5.4.3 Regulatory Framework
    • 6.5.4.4 Reimbursement scenario
    • 6.5.4.5 Mexico Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Europe
  • 6.5.6. Europe Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. UK
    • 6.5.7.1 Key Country Dynamics
    • 6.5.7.2 Competitive Scenario
    • 6.5.7.3 Regulatory Framework
    • 6.5.7.4 Reimbursement scenario
    • 6.5.7.5 UK Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Germany
    • 6.5.8.1 Key Country Dynamics
    • 6.5.8.2 Competitive Scenario
    • 6.5.8.3 Regulatory Framework
    • 6.5.8.4 Reimbursement scenario
    • 6.5.8.5 Germany Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. France
    • 6.5.9.1 Key Country Dynamics
    • 6.5.9.2 Competitive Scenario
    • 6.5.9.3 Regulatory Framework
    • 6.5.9.4 Reimbursement scenario
    • 6.5.9.5 France Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.10. Italy
    • 6.5.10.1 Key Country Dynamics
    • 6.5.10.2 Competitive Scenario
    • 6.5.10.3 Regulatory Framework
    • 6.5.10.4 Reimbursement scenario
    • 6.5.10.5 Italy Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.11. Spain
    • 6.5.11.1 Key Country Dynamics
    • 6.5.11.2 Competitive Scenario
    • 6.5.11.3 Regulatory Framework
    • 6.5.11.4 Reimbursement scenario
    • 6.5.11.5 Spain Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.12. Denmark
    • 6.5.12.1 Key Country Dynamics
    • 6.5.12.2 Competitive Scenario
    • 6.5.12.3 Regulatory Framework
    • 6.5.12.4 Reimbursement scenario
    • 6.5.12.5 Denmark Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.13. Sweden
    • 6.5.13.1 Key Country Dynamics
    • 6.5.13.2 Competitive Scenario
    • 6.5.13.3 Regulatory Framework
    • 6.5.13.4 Reimbursement scenario
    • 6.5.13.5 Sweden Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.14. Norway
    • 6.5.14.1 Key Country Dynamics
    • 6.5.14.2 Competitive Scenario
    • 6.5.14.3 Regulatory Framework
    • 6.5.14.4 Reimbursement scenario
    • 6.5.14.5 Norway Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.15. Asia Pacific
  • 6.5.16. Asia Pacific Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.17. Japan
    • 6.5.17.1 Key Country Dynamics
    • 6.5.17.2 Competitive Scenario
    • 6.5.17.3 Regulatory Framework
    • 6.5.17.4 Reimbursement scenario
    • 6.5.17.5 Japan Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.18. China
    • 6.5.18.1 Key Country Dynamics
    • 6.5.18.2 Competitive Scenario
    • 6.5.18.3 Regulatory Framework
    • 6.5.18.4 Reimbursement scenario
    • 6.5.18.5 China Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.19. India
    • 6.5.19.1 Key Country Dynamics
    • 6.5.19.2 Competitive Scenario
    • 6.5.19.3 Regulatory Framework
    • 6.5.19.4 Reimbursement scenario
    • 6.5.19.5 India Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.20. South Korea
    • 6.5.20.1 Key Country Dynamics
    • 6.5.20.2 Competitive Scenario
    • 6.5.20.3 Regulatory Framework
    • 6.5.20.4 Reimbursement scenario
    • 6.5.20.5 South Korea Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.21. Australia
    • 6.5.21.1 Key Country Dynamics
    • 6.5.21.2 Competitive Scenario
    • 6.5.21.3 Regulatory Framework
    • 6.5.21.4 Reimbursement scenario
    • 6.5.21.5 Australia Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.22. Thailand
    • 6.5.22.1 Key Country Dynamics
    • 6.5.22.2 Competitive Scenario
    • 6.5.22.3 Regulatory Framework
    • 6.5.22.4 Reimbursement scenario
    • 6.5.22.5 Thailand Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.23. Latin America
  • 6.5.24. Latin America Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.25. Brazil
    • 6.5.25.1 Key Country Dynamics
    • 6.5.25.2 Competitive Scenario
    • 6.5.25.3 Regulatory Framework
    • 6.5.25.4 Reimbursement scenario
    • 6.5.25.5 Brazil Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.26. Argentina
    • 6.5.26.1 Key Country Dynamics
    • 6.5.26.2 Competitive Scenario
    • 6.5.26.3 Regulatory Framework
    • 6.5.26.4 Reimbursement scenario
    • 6.5.26.5 Argentina Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.27. Middle East & Africa
  • 6.5.28. Middle East & Africa Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.29. South Africa
    • 6.5.29.1 Key Country Dynamics
    • 6.5.29.2 Competitive Scenario
    • 6.5.29.3 Regulatory Framework
    • 6.5.29.4 Reimbursement scenario
    • 6.5.29.5 South Africa Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.30. Saudi Arabia
    • 6.5.30.1 Key Country Dynamics
    • 6.5.30.2 Competitive Scenario
    • 6.5.30.3 Regulatory Framework
    • 6.5.30.4 Reimbursement scenario
    • 6.5.30.5 Saudi Arabia Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.31. UAE
    • 6.5.31.1 Key Country Dynamics
    • 6.5.31.2 Competitive Scenario
    • 6.5.31.3 Regulatory Framework
    • 6.5.31.4 Reimbursement scenario
    • 6.5.31.5 UAE Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.32. Kuwait
    • 6.5.32.1 Key Country Dynamics
    • 6.5.32.2 Competitive Scenario
    • 6.5.32.3 Regulatory Framework
    • 6.5.32.4 Reimbursement scenario
    • 6.5.32.5 Kuwait Retinal Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. Vivani Medical
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Product benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Pixium Vision
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. Boston Retinal Implant Project
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. Nano Retina
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Labtician Ophthalmics, Inc.
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. LambdaVision, Inc.
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Bionic Vision Technologies
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. Nidek Co., Ltd.
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives
  • 7.2.9. Retina Implant AG
    • 7.2.9.1. Company overview
    • 7.2.9.2. Financial performance
    • 7.2.9.3. Product benchmarking
    • 7.2.9.4. Strategic initiatives
  • 7.2.10. Optobionics
    • 7.2.10.1. Company overview
    • 7.2.10.2. Financial performance
    • 7.2.10.3. Product benchmarking
    • 7.2.10.4. Strategic initiatives
  • 7.2.11. VisionCare Ophthalmic Technologies
    • 7.2.11.1. Company overview
    • 7.2.11.2. Financial performance
    • 7.2.11.3. Product benchmarking
    • 7.2.11.4. Strategic initiatives

관련자료